Literature DB >> 12845658

Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry.

Fredrik Jonsson1, Alicja Wolk, Nancy L Pedersen, Paul Lichtenstein, Paul Terry, Anders Ahlbom, Maria Feychting.   

Abstract

Obesity increases the risk of certain cancer types, e.g., cancer of the endometrium, colon and gallbladder. For some other cancer forms, e.g., prostate cancer, the association is less clear. We examined the association between body mass index (BMI) and hormone-dependent tumors, utilizing a cohort of 21,884 Swedish twins born during 1886-1925. Information about BMI at different ages and potential confounding factors was collected prospectively. The Swedish Cancer Registry was used to identify cases of cancer in the prostate (n = 666), breast (n = 607), corpus uteri (n = 150) and ovary (n = 118) during 1969-1997. The material was analyzed as a traditional cohort and with co-twin control analyses that allow for control of genetic influences. Obesity (BMI >/=30 kg/m(2)) at baseline was positively associated with cancer in the corpus uteri [relative risk (RR) = 3.03, 95% confidence interval (CI) 1.82-5.03], as was BMI at age 25, independently of BMI at baseline. Increased risk was also found for breast cancer but only in older women (>/=70 years). Overweight at age 25 was associated with decreased risk of breast cancer (RR = 0.51, 95% CI 0.33-0.78). No association was found for prostate cancer. We conclude that age is an important effect modifier of cancer risk associated with obesity and that obesity and overweight in young adult life may affect cancer risk also later in life. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12845658     DOI: 10.1002/ijc.11266

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

Review 1.  Lifestyle and dietary factors in the prevention of lethal prostate cancer.

Authors:  Kathryn M Wilson; Edward L Giovannucci; Lorelei A Mucci
Journal:  Asian J Androl       Date:  2012-04-16       Impact factor: 3.285

2.  Anthropometric characteristics and ovarian cancer risk and survival.

Authors:  Albina N Minlikeeva; Kirsten B Moysich; Paul C Mayor; John L Etter; Rikki A Cannioto; Roberta B Ness; Kristen Starbuck; Robert P Edwards; Brahm H Segal; Sashikant Lele; Kunle Odunsi; Brenda Diergaarde; Francesmary Modugno
Journal:  Cancer Causes Control       Date:  2018-01-11       Impact factor: 2.506

3.  Body size and breast cancer risk: the Multiethnic Cohort.

Authors:  Kami K White; Song-Yi Park; Laurence N Kolonel; Brian E Henderson; Lynne R Wilkens
Journal:  Int J Cancer       Date:  2012-01-27       Impact factor: 7.396

4.  Examining the relationship between obesity and prostate cancer.

Authors:  Stephen J Freedland; William J Aronson
Journal:  Rev Urol       Date:  2004

5.  Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy.

Authors:  Kozhaya N Mallah; Christopher J DiBlasio; Audrey C Rhee; Peter T Scardino; Michael W Kattan
Journal:  Cancer       Date:  2005-05-15       Impact factor: 6.860

Review 6.  Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies.

Authors:  Leo J Schouten; Christine Rivera; David J Hunter; Donna Spiegelman; Hans-Olov Adami; Alan Arslan; W Lawrence Beeson; Piet A van den Brandt; Julie E Buring; Aaron R Folsom; Gary E Fraser; Jo L Freudenheim; R Alexandra Goldbohm; Susan E Hankinson; James V Lacey; Michael Leitzmann; Annekatrin Lukanova; James R Marshall; Anthony B Miller; Alpa V Patel; Carmen Rodriguez; Thomas E Rohan; Julie A Ross; Alicja Wolk; Shumin M Zhang; Stephanie A Smith-Warner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04-01       Impact factor: 4.254

7.  The impact of BMI on subgroups of uterine cancer.

Authors:  K Lindemann; L J Vatten; M Ellstrøm-Engh; A Eskild
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

8.  Body mass index and cancer incidence: the FINRISK study.

Authors:  Xin Song; Eero Pukkala; Tadeusz Dyba; Jaakko Tuomilehto; Vladislav Moltchanov; Satu Männistö; Pekka Jousilahti; Qing Qiao
Journal:  Eur J Epidemiol       Date:  2014-07-06       Impact factor: 8.082

9.  Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis.

Authors:  Luisa Zuccolo; Ross Harris; David Gunnell; Steven Oliver; Jane Athene Lane; Michael Davis; Jenny Donovan; David Neal; Freddie Hamdy; Rebecca Beynon; Jelena Savovic; Richard Michael Martin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

Review 10.  The impact of obesity on prostate cancer.

Authors:  Joep G H van Roermund; J Alfred Witjes
Journal:  World J Urol       Date:  2007-05-30       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.